Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. CHIPOTLE: Earlier this week, Chipotle Mexican grill (CMG) said employees will be able to earn up to $1,000 extra this year due to the new tax legislation. The company’s CFO Jack Hartung explained on Tuesday that about a third of the burrito chain’s tax savings will go directly to its employees in the form of a one-time cash bonus, with Chipotle also awarding a one-time stock bonus to a group of staff. 2. APPLE: Apple (AAPL) is cutting back on buying corporate bonds with its overseas cash as it prepares to repatriate billions of dollars in overseas cash under the Trump tax cuts, Bloomberg reported earlier this week, citing unnamed sources. The pullback in buying, echoed by other tech firms with sizable overseas holdings, could have an impact on corporate borrowing costs, the report added. 3. CISCO: The Information said on Monday that Cisco (CSCO) CEO Chuck Robbins hinted in a recent meeting with reseller partners that his company would use some of the $68B it holds overseas for acquisitions now that U.S. tax reform legislation has passed. Cisco is said to have looked at ServiceNow (NOW) and Red Hat (RHT) as potential targets, the report indicated. 4. PHARMA: Following President Trump’s recent declaration in the State of the Union address that drug prices were one of his “greatest priorities,” the White House Council of Economic Advisors issued a White Paper on potential drug price reforms. Among the proposals: CMS could revise Medicaid rules to specify how best prices are calculated and provide more guidance on how value-based contracts and price reporting would affect other price regulations; ways to facilitate more expedited reviews of drugs by the FDA; the U.S. could take action to change incentives for other countries to price drugs at levels that appropriately reward innovation; possible changes to Medicare Part B and Part D; and use of a single agency that could set prices at which the eligible providers can buy drugs under the 340B program. 5. SOLAR AND RENEWABLES: Xia Aimin, global marketing director at Longi Green Energy Tech, said that the U.S. will need to offer incentives to draw investment from foreign solar firms following the implementation of steep tariffs on solar panel imports by President Donald Trump, according to Reuters. The Chinese solar maker, which is investing $309M to double the total capacity of a cell factory and module plant in India, said it will not exit the U.S. market as a result of the tariffs but it still needs to assess the impact of the new policy. Publicly traded companies in the solar space include Canadian Solar (CSIQ), SunPower (SPWR), First Solar (FSLR), JA Solar (JASO), JinkoSolar (JKS) and Yingli Green Energy (YGE). Meanwhile, Roth Capital analyst Craig Irwin upgraded FuelCell (FCEL) to Buy from Neutral on Friday, noting that the federal budget deal reached reinstates the eligibility of fuel cells for the Investment Tax Credit and harmonizes the credit with 30% levels currently available for solar power. “Week in Review” is The Fly’s weekly recap of its recurring series of “Trump Effect” exclusive stories.
previous post